Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 927 Lymphoma 112 Recurrence 94 Neoplasms, Plasma Cell 92 Lymphoma, Non-Hodgkin 67 Immunoglobulin Light-chain Amyloidosis 60 Hematologic Neoplasms 60 Neoplasms 54 Smoldering Multiple Myeloma 51 Leukemia, Myeloid, Acute 51 Leukemia 51 Myelodysplastic Syndromes 47 Leukemia, Lymphocytic, Chronic, B-Cell 45 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Hodgkin Disease 37 Leukemia, Plasma Cell 26 Myeloproliferative Disorders 24 Monoclonal Gammopathy of Undetermined Significance 23 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Mantle-Cell 22 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22 Breast Neoplasms 22 Amyloidosis 22 Primary Myelofibrosis 21 Lymphoma, Follicular 21 Waldenstrom Macroglobulinemia 20 Ovarian Neoplasms 18 Lymphoma, B-Cell, Marginal Zone 17 Lymphoma, B-Cell 17 Colorectal Neoplasms 16

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anosmia × Plasma cell × 1 year × Clear all

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡